Skip to content

Playground build · Anything marked “Sample data” is fictional

H.R. 2483 · 119th Congress · Public Law 119-44

SUPPORT for Patients and Communities Reauthorization Act of 2025

34 sections in the law; 3 added after the bill was introduced.

Signed December 1, 2025 · Introduced March 31, 2025 in the House

Sponsor: Rep. Brett Guthrie (R-KY-2) · 1 cosponsor (1 D)

Download the cardCongress.gov ↗ (opens in new tab)

Our check

Grade: Pending review

Not checked yet. No section of this law gets a verdict until a person approves the check.

Grade = share of sections a reviewed check found not described by the bill’s title or summary: Prime Cut 0%, Lean up to 5%, Marbled up to 20%, Pork Barrel over 20%. Pending review until a person has approved the check. How we decide

X-ray · every section, in order

  1. Sec. 1 Short title; table of contents, in the bill as introduced
  2. Sec. 101 Prenatal and postnatal health, in the bill as introduced
  3. Sec. 102 Monitoring and education regarding infections associated with illicit drug use and other risk factors, in the bill as introduced
  4. Sec. 103 Preventing overdoses of controlled substances, in the bill as introduced
  5. Sec. 104 Support for individuals and families impacted by fetal alcohol spectrum disorder, in the bill as introduced
  6. Sec. 105 Promoting state choice in PDMP systems, in the bill as introduced
  7. Sec. 106 First responder training program, in the bill as introduced
  8. Sec. 107 Donald J. Cohen National Child Traumatic Stress Initiative, in the bill as introduced
  9. Sec. 108 Protecting suicide prevention lifeline from cybersecurity incidents, in the bill as introduced
  10. Sec. 109 Monitoring and reporting of child, youth, and adult trauma, in the bill as introduced
  11. Sec. 110 Bruce’s law, in the bill as introduced
  12. Sec. 111 Guidance on at-home drug disposal systems, in the bill as introduced
  13. Sec. 112 Assessment of opioid drugs and actions, in the bill as introduced
  14. Sec. 113 Grant program for State and Tribal response to opioid use disorders, in the bill as introduced
  15. Sec. 201 Residential treatment program for pregnant and postpartum women, in the bill as introduced
  16. Sec. 202 Improving access to addiction medicine providers, in the bill as introduced
  17. Sec. 203 Mental and behavioral health education and training grants, in the bill as introduced
  18. Sec. 204 Loan repayment program for substance use disorder treatment workforce, in the bill as introduced
  19. Sec. 205 Development and dissemination of model training programs for substance use disorder patient records, in the bill as introduced
  20. Sec. 206 Task force on best practices for trauma-informed identification, referral, and support, in the bill as introduced
  21. Sec. 207 Grants to enhance access to substance use disorder treatment, in the bill as introduced
  22. Sec. 208 State guidance related to individuals with serious mental illness and children with serious emotional disturbance, in the bill as introduced
  23. Sec. 209 Reviewing the scheduling of approved products containing a combination of buprenorphine and naloxone, in the bill as introduced
  24. Sec. 210 References to opioid overdose reversal agents in HHS grant programs, added in Engrossed in House
  25. Sec. 211 Roundtable on using health information technology to improve mental health and substance use care outcomes, added in Engrossed in House
  26. Sec. 301 Building communities of recovery, in the bill as introduced
  27. Sec. 302 Peer support technical assistance center, in the bill as introduced
  28. Sec. 303 Comprehensive opioid recovery centers, in the bill as introduced
  29. Sec. 304 Youth prevention and recovery, in the bill as introduced
  30. Sec. 305 CAREER Act, in the bill as introduced
  31. Sec. 306 Addressing economic and workforce impacts of the opioid crisis, in the bill as introduced
  32. Sec. 307 Review of information related to funding opportunities under programs administered by SAMHSA, added in Engrossed in House
  33. Sec. 401 Delivery of a controlled substance by a pharmacy to a prescribing practitioner, in the bill as introduced
  34. Sec. 402 Required training for prescribers of controlled substances, in the bill as introduced

The yardstick

What the law says it does

A check compares every section with these texts, and nothing else.

Official title

To reauthorize certain programs that provide for opioid use disorder prevention, treatment, and recovery, and for other purposes.

Official summary (Congressional Research Service) · as public law

TITLE I--PREVENTION

(Sec. 101) This section reauthorizes through FY2030 Centers for Disease Control and Prevention (CDC) programs that provide information, grants, and technical assistance relating to studying and preventing prenatal and postnatal substance use disorders.

(Sec. 102) This section reauthorizes through FY2030 CDC programs that carry out and provide grants for surveillance, treatment, and education relating to infections associated with illicit drug use.

(Sec. 103) This section reauthorizes through FY2030 and expands CDC programs that carry out activities and provide grants relating to monitoring drug use and overdoses (e.g., supporting state prescription drug monitoring programs), preventing and responding to substance use disorders, and raising awareness regarding opioids and other substances.

The section authorizes additional activities, including wastewater surveillance and collecting data on risk factors associated with overdoses.

(Sec. 104) This section reestablishes, expands, and provides statutory authority for Department of Health and Human Services (HHS) activities addressing fetal alcohol spectrum disorders (i.e., conditions caused by prenatal alcohol exposure), including carrying out and providing grants for research, education and public awareness, and intervention and support services for affected individuals.

(Sec. 105) This section specifies that, in providing grants to support state prescription drug monitoring programs, the CDC is not authorized to require states to use specific vendors or interoperability systems other than to align with general, consensus-based standards for interoperability.

(Sec. 106) This section reauthorizes through FY2030 and expands grants to government entities to provide first responders with opioid overdose reversal drugs (e.g., naloxone) and related training. The grant program is administered by the Substance Abuse and Mental Health Services Administration (SAMHSA).

The section expands the program to include (1) treatment and training for overdoses from other drugs besides opioids, and (2) treatment with drugs or devices that are legally marketed under applicable law. Current law limits the program to addressing opioid overdoses and to drugs or devices that are officially approved or cleared by the Food and Drug Administration (FDA).

(Sec. 107) This section reauthorizes through FY2030 and revises the National Child Traumatic Stress Initiative and related activities, which are administered by SAMHSA. Under the initiative, SAMHSA provides grants and other support to improve the quality of and increase access to services addressing psychological trauma in youth and families.

The section requires grant recipients to develop training and other resources for collaborative implementation of best practices.

(Sec. 108) This section requires SAMHSA to undertake efforts to protect the 9-8-8 Suicide & Crisis Lifeline from cybersecurity threats. (The lifeline is a three-digit number that connects callers in suicidal crisis or mental health distress to a national network of crisis centers.) The section includes requirements for the lifeline’s network administrator and participating local and regional crisis centers to report identified cybersecurity incidents and vulnerabilities.

The Government Accountability Office must conduct a study that evaluates cybersecurity risks and vulnerabilities associated with the lifeline and report the findings to Congress.

(Sec. 109) This section reauthorizes through FY2030 CDC activities to collect and report certain public health data relating to potentially traumatic childhood experiences.

(Sec. 110) This section reauthorizes through FY2030 an interdepartmental committee on substance use disorders, establishes an interagency work group on fentanyl contamination of illegal drugs, and expands certain SAMHSA activities to include supporting strategies to raise awareness about the dangers of synthetic opioids for youth.

(Sec. 111) This section requires HHS to publish guidance regarding at-home safe drug disposal systems.

(Sec. 112) This section requires HHS to publish a plan for assessing approved opioid analgesic drugs (i.e., opioid pain relievers) that addresses the public health effects of these drugs, including updates on actions by the FDA with respect to risk-benefit assessments and supporting development and approval of nonaddictive medical products. HHS must provide an opportunity for public input on the FDA’s regulation of opioid analgesic drugs.

(Sec. 113) This section provides statutory authority for SAMHSA’s State Opioid Response and Tribal Opioid Response Grants to be used for facilitating access to drug checking technologies, such as fentanyl and xylazine test strips, to the extent permitted by federal and state law.

TITLE II--TREATMENT

(Sec. 201) This section reauthorizes through FY2030 the Residential Treatment for Pregnant and Postpartum Women program, which is administered by the Center for Substance Abuse Treatment within SAMHSA. This program awards grants to fund services for pregnant and postpartum women with substance use disorders, including services for treatment, recovery support, and case management.

The section also specifically allows grant recipients to conduct outreach that is targeted at women disproportionately impacted by maternal substance use disorders.

(Sec. 202) This section provides statutory authority for the Minority Fellowship Program to include fellowships for training in the field of addiction medicine. The Minority Fellowship Program, administered by SAMHSA, funds fellowships for individuals seeking graduate degrees and planning to work on addressing mental or substance use disorders in racial and ethnic minority populations.

(Sec. 203) This section reauthorizes through FY2030 the Behavioral Health Workforce Education and Training Program for Professionals, which is administered by the Health Resources and Services Administration (HRSA). This program provides grants to educational organizations and programs to recruit and educate students in mental and behavioral health.

(Sec. 204) This section reauthorizes through FY2030 the Substance Use Disorder Treatment and Recovery Loan Repayment Program, which is administered by HRSA. This program provides repayment of educational loans for health care practitioners who agree to provide direct treatment or recovery support for substance use disorders in certain areas with shortages of health professionals or high rates of overdose.

(Sec. 206) This section reauthorizes through FY2030 and expands an interagency task force that must develop recommendations relating to (1) best practices for preventing and mitigating trauma in youth and (2) coordinating the federal response to families impacted by substance use disorders and other trauma.

(Sec. 208) This section requires SAMHSA to conduct a review of how states use funds under the Community Mental Health Services Block Grant program to address first episode psychosis, including the use of evidence-based services for individuals with early serious mental illness and children with serious emotional disturbance. SAMHSA must report to Congress on the findings of the review and update the guidance for the block grant program based on such findings.

(Sec. 209) This section requires HHS to review relevant data and, if determined appropriate, request that the Drug Enforcement Administration (DEA) revise the scheduling of approved products containing a combination of buprenorphine and naloxone under the Controlled Substances Act. The DEA must review such requests and determine whether to revise the schedules.

(Sec. 210) This section requires that, when HHS issues new regulations or guidance on grant programs addressing opioid use disorders, references to an opioid overdose reversal drug (e.g., naloxone) must broadly include any opioid overdose reversal drug approved by the FDA.

Within one year after the act’s enactment, HHS must update all references accordingly in regulations or guidance issued prior to the act’s enactment that are applicable to State Opioid Response Grants, Tribal Opioid Response Grants, or certain other grants relating to substance use disorder prevention.

(Sec. 211) This section requires HHS to convene a public roundtable with public and private stakeholders on expanding the use of electronic health records among mental health and substance use disorder service providers. HHS must report to Congress on the results of the roundtable with respect to specified topics.

TITLE III--RECOVERY

(Sec. 301) This section reauthorizes through FY2030 the Building Communities of Recovery program, which is administered by the Center for Substance Abuse Treatment within SAMHSA. This program provides grants to certain community nonprofit organizations for developing and delivering coordinated community and statewide recovery support services for individuals with substance use disorders.

(Sec. 302) This section reauthorizes through FY2030 and expands the National Peer-Run Training and Technical Assistance Center for Addiction Recovery Support, which is administered by SAMHSA. The center provides training and resources to public and private nonprofit entities relating to recovery support services for substance use disorders and co-occurring conditions (i.e., mental health conditions coexisting with substance use disorders).

The section expands the center's functions to include professional development of peer support specialists and recovery support services in nonclinical settings. It also authorizes through FY2030 a regional technical assistance center to support the ability of the center to meet a particular region's needs.

(Sec. 303) This section reauthorizes through FY2030 grants to nonprofits for establishing or operating opioid recovery centers providing comprehensive treatment and recovery support services. The grant program is administered by SAMHSA.

(Sec. 304) This section reauthorizes through FY2030 and revises the Preventing Youth Overdose: Treatment, Recovery, Education, Awareness, and Training (PYO-TREAT) program, which is administered by SAMHSA. The PYO-TREAT program provides grants and other support to educational and public entities for substance use disorder prevention, treatment, and recovery for children and young adults.

The section revises the program to provide statutory authority for (1) requiring applicants to submit plans for sustaining activities under the program after the grant has ended, and (2) expanding eligible grant recipients to include consortia of local educational agencies. SAMHSA must report to Congress on the PYO-TREAT program’s effectiveness.

(Sec. 305) This section reauthorizes through FY2030 and expands the Treatment, Recovery, and Workforce Support program, which is administered by SAMHSA. This program provides grants to public and private nonprofit entities to support individuals in treatment and recovery for substance use disorders and co-occurring conditions to live independently and participate in the workforce.

The section authorizes using 5% of such grant funds for transportation services and requires grant recipients to report on the employment and earnings outcomes of program participants.

Also, the section reauthorizes through FY2030 the Recovery Housing Pilot Program, which assists states in providing individuals in recovery from a substance use disorder with stable, temporary housing for up to two years. This program is administered by the Department of Housing and Urban Development.

(Sec. 306) This section reauthorizes through FY2030 the Support to Communities: Fostering Opioid Recovery through Workforce Development program, which is administered by the Department of Labor. This program provides grants to public entities to address the economic and workforce-related impacts of substance use disorders through activities such as screening and support services, training, and engaging with employers.

(Sec. 307) This section requires HHS to convene a public meeting relating to improving awareness of and access to grants provided by SAMHSA. Based on the stakeholder feedback received at the meeting, HHS must implement improvements to relevant websites and report to Congress.

TITLE IV--MISCELLANEOUS MATTERS

(Sec. 401) This section allows pharmacies to deliver to prescribing practitioners schedule III-V controlled substances that are not directly administered by the practitioner (i.e., self-administered), provided the controlled substances are subject to a risk evaluation and mitigation strategy to assure safe use by the patient, including post-administration monitoring by a health care provider.

(Sec. 402) This section expands the types of organizations that may provide training or education required for practitioners registering with the DEA to dispense (i.e., prescribe or administer) schedule II-V controlled substances. This section applies retroactively, taking effect as if enacted on December 29, 2022.

How it grew

3 sections added after the bill was introduced

The bill had 31 sections when it was introduced. A section counts as added when it can’t be traced to the introduced text through the earlier versions and no introduced section has the same heading. Being added says nothing about whether a section is good or bad, or why it was added.

  1. Sec. 210References to opioid overdose reversal agents in HHS grant programsFirst appears in: Engrossed in House
  2. Sec. 211Roundtable on using health information technology to improve mental health and substance use care outcomesFirst appears in: Engrossed in House
  3. Sec. 307Review of information related to funding opportunities under programs administered by SAMHSAFirst appears in: Engrossed in House

How it became law

  1. IntroducedMar 31
  2. CommitteeApr 29
  3. House—
  4. SenateSep 18
  5. SignedDec 1

As introduced: To reauthorize certain programs that provide for opioid use disorder prevention, treatment, and recovery, and for other purposes.

Key steps, cosponsors and text changes (21)

  1. Sponsor

    Rep. Brett Guthrie (R-KY)

  2. Original cosponsors

    Rep. Brittany Pettersen (D-CO)

  3. Introduced in House

  4. Text: Introduced in House

    31 sections

  5. HouseOrdered to be Reported (Amended) by the Yeas and Nays: 36 - 13.

  6. HouseCommittee on Financial Services discharged.

  7. HouseCommittee on the Judiciary discharged.

  8. HouseCommittee on Education and Workforce discharged.

  9. HouseReported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-114, Part I.

  10. Text: Reported in House

    31 sections: 2 reworded

  11. HouseOn passage Passed by the Yeas and Nays: 366 - 57 (Roll no. 151).

  12. Text: Engrossed in House

    34 sections: 3 added, 1 reworded

  13. SenateReceived in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

  14. Text: Referred in Senate

    34 sections, no changes

  15. SenatePassed Senate without amendment by Unanimous Consent. (consideration: CR S6712)

  16. SenateSenate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.

  17. HousePresented to President.

  18. Text: Enrolled Bill

    34 sections, no changes

  19. Became Public Law No: 119-44.

  20. Became Public Law No: 119-44

  21. Signed by President.

Show every recorded step (39)

  1. Sponsor

    Rep. Brett Guthrie (R-KY)

  2. Original cosponsors

    Rep. Brittany Pettersen (D-CO)

  3. HouseReferred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, the Judiciary, and Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  4. Introduced in House

  5. Text: Introduced in House

    31 sections

  6. HouseOrdered to be Reported (Amended) by the Yeas and Nays: 36 - 13.

  7. HouseCommittee Consideration and Mark-up Session Held

  8. HouseCommittee on Financial Services discharged.

  9. HouseCommittee on the Judiciary discharged.

  10. HouseCommittee on Education and Workforce discharged.

  11. HouseReported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-114, Part I.

  12. Text: Reported in House

    31 sections: 2 reworded

  13. HouseRules Committee Resolution H. Res. 458 Reported to House. Rule provides for consideration of H.R. 2483, H.R. 2931, H.R. 2966 and H.R. 2987. The resolution provides for consideration of H.R. 2483 under a structured rule and for consideration of H.R. 2931, H.R. 2966, and H.R. 2987 under a closed rule. The resolution provides for one hour of debate and one motion to recommit on each bill.

  14. HouseOn passage Passed by the Yeas and Nays: 366 - 57 (Roll no. 151).

  15. HouseThe House adopted the amendments en gros as agreed to by the Committee of the Whole House on the state of the Union.

  16. HouseThe previous question was ordered pursuant to the rule.

  17. HouseThe House rose from the Committee of the Whole House on the state of the Union to report H.R. 2483.

  18. HouseThe House resolved into Committee of the Whole House on the state of the Union for further consideration.

  19. HouseConsidered as unfinished business. (consideration: CR H2456-2457)

  20. HouseCommittee of the Whole House on the state of the Union rises leaving H.R. 2483 as unfinished business.

  21. HouseOn motion that the committee rise Agreed to by voice vote.

  22. HouseMr. Wittman moved that the committee rise.

  23. HouseDEBATE - Pursuant to the provisions of H.Res. 458, the Committee of the Whole proceeded with 10 minutes of debate on the Wittman amendment No. 4.

  24. HousePOSTPONED PROCEEDINGS - At the conclusion of debate on the Pettersen amendment, the Chair put the question on agreeing to the amendment and by voice vote, announced the noes had prevailed. Ms. Pettersen demanded a recorded vote, and the Chair postponed further proceedings until a time to be announced.

  25. HouseGENERAL DEBATE - The Committee of the Whole proceeded with one hour of general debate on H.R. 2483.

  26. HouseThe Speaker designated the Honorable Scott DesJarlais to act as Chairman of the Committee.

  27. HouseHouse resolved itself into the Committee of the Whole House on the state of the Union pursuant to H. Res. 458 and Rule XVIII.

  28. HouseRule provides for consideration of H.R. 2483, H.R. 2931, H.R. 2966 and H.R. 2987. The resolution provides for consideration of H.R. 2483 under a structured rule and for consideration of H.R. 2931, H.R. 2966, and H.R. 2987 under a closed rule. The resolution provides for one hour of debate and one motion to recommit on each bill.

  29. HouseConsidered under the provisions of rule H. Res. 458. (consideration: CR H2441-2456; text: CR H2447-2543)

  30. Text: Engrossed in House

    34 sections: 3 added, 1 reworded

  31. SenateReceived in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

  32. Text: Referred in Senate

    34 sections, no changes

  33. SenatePassed Senate without amendment by Unanimous Consent. (consideration: CR S6712)

  34. SenateSenate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.

  35. HousePresented to President.

  36. Text: Enrolled Bill

    34 sections, no changes

  37. Became Public Law No: 119-44.

  38. Became Public Law No: 119-44

  39. Signed by President.

Source: GovInfo bill status and text versions. 1 cosponsors.

Every section

All 34 sections, in order

From the enrolled bill text on GovInfo. Read any section in full on Congress.gov.

  1. Sec. 1Short title; table of contents
  2. Sec. 101Prenatal and postnatal health
  3. Sec. 102Monitoring and education regarding infections associated with illicit drug use and other risk factors
  4. Sec. 103Preventing overdoses of controlled substances
  5. Sec. 104Support for individuals and families impacted by fetal alcohol spectrum disorder
  6. Sec. 105Promoting state choice in PDMP systems
  7. Sec. 106First responder training program
  8. Sec. 107Donald J. Cohen National Child Traumatic Stress Initiative
  9. Sec. 108Protecting suicide prevention lifeline from cybersecurity incidents
  10. Sec. 109Monitoring and reporting of child, youth, and adult trauma
  11. Sec. 110Bruce’s law
  12. Sec. 111Guidance on at-home drug disposal systems
  13. Sec. 112Assessment of opioid drugs and actions
  14. Sec. 113Grant program for State and Tribal response to opioid use disorders
  15. Sec. 201Residential treatment program for pregnant and postpartum women
  16. Sec. 202Improving access to addiction medicine providers
  17. Sec. 203Mental and behavioral health education and training grants
  18. Sec. 204Loan repayment program for substance use disorder treatment workforce
  19. Sec. 205Development and dissemination of model training programs for substance use disorder patient records
  20. Sec. 206Task force on best practices for trauma-informed identification, referral, and support
  21. Sec. 207Grants to enhance access to substance use disorder treatment
  22. Sec. 208State guidance related to individuals with serious mental illness and children with serious emotional disturbance
  23. Sec. 209Reviewing the scheduling of approved products containing a combination of buprenorphine and naloxone
  24. Sec. 210References to opioid overdose reversal agents in HHS grant programsAdded in: Engrossed in House
  25. Sec. 211Roundtable on using health information technology to improve mental health and substance use care outcomesAdded in: Engrossed in House
  26. Sec. 301Building communities of recovery
  27. Sec. 302Peer support technical assistance center
  28. Sec. 303Comprehensive opioid recovery centers
  29. Sec. 304Youth prevention and recovery
  30. Sec. 305CAREER Act
  31. Sec. 306Addressing economic and workforce impacts of the opioid crisis
  32. Sec. 307Review of information related to funding opportunities under programs administered by SAMHSAAdded in: Engrossed in House
  33. Sec. 401Delivery of a controlled substance by a pharmacy to a prescribing practitioner
  34. Sec. 402Required training for prescribers of controlled substances

Sponsor and cosponsors

Show all 2 members, by last name

Sponsor: Rep. Brett Guthrie (R-KY-2)

  • Rep. Brittany Pettersen (D-CO-7)
Share card: SUPPORT for Patients and Communities Reauthorization Act of 2025, 34 sections in the law; 3 added after the bill was introduced.

Share this law

The card shows the section count and how many were added. No sponsor, party or state.

Download image

Sources: bill text and status, GovInfo (Enrolled Bill) · Official summary, Congressional Research Service · Congress.gov, as of November 1, 2026. US government works are in the public domain · This bill on Congress.gov (opens in new tab)